Our Pricing

Mounjaro And Period Cramps: What Are The Side Effects?

Concerns about mounjaro and period cramps uk are increasingly common as more women begin tirzepatide treatment for weight loss. While Mounjaro primarily targets appetite and blood sugar regulation, hormonal changes during significant weight loss can affect menstrual cycles, potentially causing cramping, irregular bleeding, or changes in flow intensity.

How Mounjaro Affects Menstrual Cycles and Period Cramps

Mounjaro (tirzepatide) is a dual GIP/GLP-1 receptor agonist licensed by the MHRA for weight management in the UK [1]. Whilst tirzepatide does not directly alter reproductive hormones, the substantial weight loss it produces can trigger hormonal adjustments that affect menstruation. Adipose tissue stores oestrogen, and as body fat decreases, oestrogen levels fluctuate, which may lead to cycle irregularities, heavier or lighter periods, and increased cramping in some women [2].

Clinical trials of tirzepatide reported menstrual disorders in a small percentage of female participants, though these were generally mild and resolved within the first three months of treatment [1]. Period cramps specifically are not listed as a direct side effect of Mounjaro, but hormonal shifts during rapid weight loss can exacerbate dysmenorrhoea (painful periods) in women already prone to cramping. If you experience severe or persistent pelvic pain whilst on Mounjaro, contact your UK prescriber to rule out other causes such as ovarian cysts or endometriosis.

It is also worth noting that weight loss itself often improves conditions like polycystic ovary syndrome (PCOS), which can normalise menstrual cycles over time. Many women find that initial irregularities settle as their body adjusts to a healthier weight and stable hormone levels [3].

Common Menstrual Side Effects Reported with Mounjaro

Women using Mounjaro have reported several menstrual changes during treatment, particularly in the first 12 weeks. These include irregular cycle length, spotting between periods, heavier or lighter menstrual flow, and increased premenstrual cramping. In the SURPASS trials, menstrual irregularities were documented in approximately 3-5% of female participants, with most cases resolving without intervention [1].

Cramping intensity may increase temporarily as oestrogen levels fluctuate. This is a recognised phenomenon during weight loss and is not unique to tirzepatide—similar reports exist for semaglutide and liraglutide users [2]. If cramping becomes severe enough to interfere with daily activities, over-the-counter pain relief such as ibuprofen or paracetamol may help, but always consult your prescriber before adding new medications.

When Menstrual Changes Require Medical Review

You should contact your UK prescriber if you experience bleeding that soaks through a pad or tampon every hour for several hours, periods lasting longer than seven days, severe pelvic pain not relieved by standard painkillers, or any bleeding after menopause. These symptoms may indicate conditions unrelated to Mounjaro that require investigation.

Does Mounjaro Affect Fertility or Contraception?

Mounjaro and period cramps UK discussions often extend to fertility concerns. Tirzepatide is not a contraceptive and does not directly impair fertility. In fact, weight loss achieved through Mounjaro may improve fertility in women with obesity-related anovulation or PCOS [3]. However, rapid hormonal changes can temporarily affect ovulation timing, making natural family planning methods less reliable during the first few months of treatment.

If you are using oral contraceptive pills, be aware that gastrointestinal side effects such as vomiting or severe diarrhoea—common with Mounjaro—can reduce contraceptive efficacy. The MHRA advises using additional barrier contraception if vomiting occurs within 3-4 hours of taking your pill. Women planning pregnancy should discontinue Mounjaro at least two months before trying to conceive, as tirzepatide has not been studied in pregnant women and animal studies suggest potential risks [1].

Managing Contraception During Mounjaro Treatment

Discuss contraceptive options with your UK prescriber before starting Mounjaro. Long-acting reversible contraceptives (LARCs) such as the implant or intrauterine system are not affected by gastrointestinal symptoms and may be preferable if you experience nausea or vomiting. Always inform your prescriber if you are planning pregnancy or suspect you may be pregnant whilst on tirzepatide.

Managing Period Cramps While Taking Mounjaro

If you develop period cramps after starting Mounjaro, several strategies may help. Non-steroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen are effective for menstrual pain and can be used alongside tirzepatide, provided you have no contraindications such as a history of stomach ulcers. Paracetamol is a suitable alternative if NSAIDs are unsuitable [4].

Heat therapy—using a hot water bottle or heating pad on the lower abdomen—can relieve cramping by relaxing uterine muscles. Gentle exercise such as walking or yoga may also reduce pain intensity by improving blood flow and releasing endorphins. Staying well-hydrated and maintaining balanced nutrition supports hormonal regulation during weight loss, which may reduce menstrual irregularities over time.

If cramping persists beyond three months or worsens, your UK prescriber may recommend adjusting your Mounjaro dose or investigating other causes. Some women benefit from hormonal treatments such as the combined oral contraceptive pill or the Mirena coil, which can reduce menstrual flow and cramping independently of weight loss medication.

Mounjaro vs Other Weight Loss Treatments: Menstrual Side Effects

Menstrual changes are not unique to Mounjaro. Wegovy (semaglutide) and Saxenda (liraglutide), both GLP-1 receptor agonists available at Cured Pharmacy, have similar reports of cycle irregularities during the weight loss phase [2]. The mechanism is the same: substantial fat loss leads to hormonal fluctuations that temporarily affect menstruation.

Orlistat-based treatments such as Xenical or Alli work differently—by blocking fat absorption in the gut—and are less likely to cause menstrual changes because weight loss is typically more gradual. However, orlistat can cause gastrointestinal side effects that some women find more troublesome than the hormonal adjustments seen with injectable treatments. Your UK prescriber will help you choose the most appropriate option based on your medical history, weight loss goals, and tolerance for different side effect profiles.

Choosing the Right Weight Loss Treatment for Women

Women with pre-existing menstrual disorders such as endometriosis or heavy menstrual bleeding may prefer treatments with more predictable hormonal effects. Your prescriber at Cured Pharmacy will assess your full medical history during the free online consultation to recommend the safest and most effective option. All prescription weight loss treatments require clinical assessment by a UK-registered prescriber before dispensing.

When to Seek Medical Advice About Mounjaro and Period Symptoms

Most menstrual changes during Mounjaro treatment are temporary and resolve within 8-12 weeks as your body adjusts to weight loss. However, certain symptoms warrant prompt medical review. Contact your UK prescriber or GP if you experience sudden severe pelvic pain, particularly if accompanied by fever or unusual vaginal discharge, as this may indicate pelvic inflammatory disease or ovarian pathology unrelated to tirzepatide [4].

Abnormally heavy bleeding (soaking through sanitary products hourly), bleeding that continues beyond seven days, or any postmenopausal bleeding should be investigated urgently. These symptoms are unlikely to be caused by Mounjaro alone and may require gynaecological assessment. Similarly, if you develop new-onset severe headaches, visual disturbances, or leg swelling alongside menstrual changes, seek immediate medical attention to rule out serious complications.

Ongoing Monitoring During Mounjaro Treatment

At Cured Pharmacy, our UK-registered clinical team provides ongoing support throughout your treatment. If you have concerns about menstrual side effects or any other symptoms, you can contact the pharmacy on (+44) 116 4646009 for advice. Regular follow-up consultations ensure your treatment remains safe and effective as your body adapts to weight loss. Superintendent pharmacist Tarun Kumar (GPhC 2233073) oversees all clinical services to maintain the highest standards of patient care.

Scientific References

1. Jastreboff, A. M., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038
2. Wilding, J. P. H., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183
3. Teede, H. J., et al. (2023). Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome. Fertility and Sterility, 120(4), 767–793. https://doi.org/10.1016/j.fertnstert.2023.07.025
4. National Institute for Health and Care Excellence. (2022). Heavy menstrual bleeding: assessment and management (NG88). NICE guideline. https://www.nice.org.uk/guidance/ng88

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.